Partners News Radboudumc and Eindhoven University of Technology join forces in BIOTRIP

1 July 2021

Radboudumc and Eindhoven University of Technology present: BIOTRIP. This independent biotech incubator aims to ensure human health through cutting edge biotech. BIOTRIP is a unique platform that brings together medical scientists and entrepreneurial biomedical engineers to work with biotech entrepreneurs. They develop, commercialize and make available vaccines and immunotherapies to patients with a variety of diseases.

Read more (in Dutch)

Related news items


Aftermovie Investment Day 2022 and a new date for 2023!

13 December 2022

Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.

read more

Successful matchmaking at Radboudumc Investment Day  

7 October 2022

On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.

read more

Radboudumc Investment Day 2022

26 September 2022

Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!

read more

Xenikos enrolls first patient in global pivotal phase 3 study evaluating T-Guard®

30 June 2022 First patient dosed in their Phase 3 study for T-Guard, a candidate for the treatment of severe acute graft-versus-host disease (aGVHD). read more

Simmunext: where immunotherapy and chemistry meet

2 June 2022 The story behind Radboud university medical center’s, Radboud University’s and Oncode’s newest spinoff, Simmunext Biotherapeutics B.V. read more

BIOTRIP vision for biotech incubator

9 November 2021 BIOTRIP, the biotech incubator, presents its vision. read more